KNC Laboratories
Basic Information
- Stock Code
- 6568
- Industry
- Services
- Category Detail
- Chemicals & Chemical Products
- Prefecture
- Hyogo Prefecture
- Establishment Year
- January 1985
- Listing Year
- March 2018
- Official Website
- https://www.kncweb.co.jp/
- TSE Information
- TSE Information
- Yahoo! Finance
- Yahoo! Finance
- Other Companies
- Osaka Organic Chemical Industry, KH Neochem, Manac CP, WDB Coco, Matsuya R&D
Overview
KNC Laboratories is a pioneering company in contract research and development services founded in 1985, with strengths in organic synthetic chemistry and biotechnology, providing advanced support to diverse industries.
Current Situation
KNC Laboratories recorded net sales of approximately 2.6 billion yen and operating profit of approximately 200 million yen for the fiscal year ended March 2021, maintaining a stable financial foundation. Its core business is contract R&D services utilizing organic synthetic chemistry and biochemistry technologies, earning trust from a wide range of pharmaceutical and chemical companies. It operates multiple research institutes and factories domestically, focusing on quality management and technology development. In recent years, it has pursued large-scale investments in culture facilities and other equipment to enhance manufacturing capabilities. In terms of sustainability, it is engaged in technology development aimed at reducing environmental impact. After listing on the Tokyo Stock Exchange Growth Market, it has leveraged raised funds to expand business scale and strengthen R&D capabilities. In the future, it aims to focus on the biotechnology sector and global expansion. Moving forward, it will continue to leverage advanced specialized technologies to provide ongoing development support tailored to customer needs.
Trivia
Interesting Facts
- High track record in domestic contract research since founding in 1985
- Listed on Tokyo Stock Exchange Growth Market in 2018
- One of Japan's first contract R&D service companies
- Operates three research and manufacturing sites domestically
- Possesses proprietary synthesis technologies with patents
- Particularly strong in culture facilities for bio field
- Approximately 300 technical staff
- Rich track record of contracts from diverse industries
- Founder is an expert in organic chemistry
- Adopts quality management system based on international standards
- Capable of custom synthesis tailored to customer needs
- Flexible small-lot, multi-variety production
- Integrated support for raw material procurement and manufacturing
- Research institutes located in Kobe and Izumo
- Actively engages in community contribution activities
Hidden Connections
- Built deep long-term partnerships with multiple major domestic pharmaceutical companies
- Participating in regional bio industry revitalization projects in collaboration with Kobe City
- Conducts numerous joint research projects with university institutions to enhance technologies
- Has influence in the Chinese market through affiliates and joint ventures
- Actively participates in technical committees of industry associations
- Among domestic bio contract companies, has high level of culture facility completeness
- Has been adapting to diverse chemical fields since founding
- Quality assurance department contributed to ISO certification acquisition and standardization
Future Outlook
Growth Drivers
- Expansion of bio-pharmaceutical market
- Increasing sophistication of contract R&D needs
- Rising pharmaceutical development investments domestically and internationally
- Growing demand for environmentally responsive manufacturing technologies
- New applications development through culture technology innovations
- Business efficiency improvements via IoT and AI adoption
- Expansion of global partnerships
- Growth in demand for sustainable chemicals
- Diversification of custom synthesis services
- Increasing demand for development support from small and medium pharmaceutical companies
- Strengthening regional medical and industrial collaborations
- Ongoing increase in R&D investments
Strategic Goals
- Achieve net sales exceeding 5 billion yen
- Expand market share in biotechnology field
- Optimize contract production system using culture facilities
- Establish zero-environmental-impact manufacturing processes
- Strengthen partnerships with major domestic and international pharmaceutical companies
- Promote digital transformation
- Establish ongoing training system to enhance employee expertise
- Achieve top ESG evaluation ranking
- Accelerate development of new technologies and services
- Incorporate and promote community contributions into management strategy
Business Segments
Pharmaceutical Manufacturing Support
- Overview
- Provides various contract services from R&D to manufacturing for pharmaceuticals.
- Competitiveness
- Product development support through integrated organic and bio technologies
- Customers
-
- Pharmaceutical Companies
- Bio Ventures
- Pharmaceutical Raw Material Manufacturers
- University Labs
- Medical Device Manufacturers
- Products
-
- Pharmaceutical APIs and Intermediates
- Manufacturing Process Development
- Quality Analysis Services
- Stable Isotope Compounds
- Culture Facility Utilization
Chemical Contract Manufacturing
- Overview
- Focuses on contract synthesis and manufacturing services for chemical products across a wide range of industries.
- Competitiveness
- High precision in synthesis and quality control technologies
- Customers
-
- Chemical Manufacturers
- Electronic Materials Manufacturers
- Functional Materials Manufacturers
- Agrochemical Manufacturers
- Materials Research Institutes
- Products
-
- Organic Chemicals Synthesis
- High-Purity Intermediates
- Functional Materials Raw Materials
- Manufacturing Consulting
- Custom Synthesis
Biotechnology Development Support
- Overview
- R&D and manufacturing support services leveraging cutting-edge bio technologies.
- Competitiveness
- Accumulated expertise in diverse culture and testing technologies
- Customers
-
- Biotechnology Companies
- Pharmaceutical Development Organizations
- University Researchers
- Public Research Institutions
- Products
-
- Cell Culture Technology
- Protein Synthesis Contract
- Bioreactor Development
- Gene-Related Testing
R&D Consulting
- Overview
- Provides technology consulting at the R&D stage to support efficient development.
- Competitiveness
- Extensive R&D know-how and networks
- Customers
-
- Pharmaceutical Companies
- Chemical Manufacturers
- New Business Development Departments
- Products
-
- Technology Evaluation
- Synthesis Design Support
- Market Research
- Quality Assurance Support
Equipment Investment and Technology Introduction Support
- Overview
- Supports enhancement of customer technical capabilities through installation of culture facilities and technology transfer.
- Competitiveness
- On-site responsiveness and equipment expertise
- Customers
-
- Small and Medium Enterprises
- Research Institutions
- Startups
- Products
-
- Culture Facility Installation
- Technology Transfer Support
- Training
Competitive Advantage
Strengths
- Advanced organic synthesis technology
- Biochemistry expertise
- Enhanced manufacturing capacity through multi-site operations
- Stable financial base
- Long track record in research contracts
- Technical research institute and lab network
- Flexible response to customer needs
- High-quality management system
- Mass production support with latest equipment
- Experienced technical staff
- Trusted relationships with domestic and international pharmaceutical manufacturers
- Active equipment investments
- Reliability as a Tokyo Stock Exchange Growth Market-listed company
- Expansion into diverse industry sectors
- Integrated support from R&D to manufacturing
Competitive Advantages
- Strength in integration of organic synthesis and bio technology
- Capability to handle a wide range of manufacturing processes on contract
- Accumulated know-how from long-term contract research
- Superior capability in small-lot, multi-variety production
- Integrated service system from research to mass production
- Differentiation through specialized culture facilities
- Strong partnerships with major domestic pharmaceutical companies
- High technical consulting capabilities
- Flexibility and rapid response to new technology introductions
- Thorough quality and delivery management
- Regionally integrated production system
- Continuous investment in cutting-edge technologies
- Development of low-environmental-impact technologies
- Transparency in equipment investment plans
- Enhanced employee expertise and training programs
Threats
- Increasing domestic and international competitors
- Risk of raw material price fluctuations
- Rising costs for stricter environmental regulations
- Risk of reduced R&D projects
- Rapid obsolescence of technologies
- Intensifying price competition in global markets
- Trend toward in-house production by customers
- Challenges in securing talent due to labor shortages
- Profit volatility from exchange rate fluctuations
- Production facility risks from natural disasters
- IP infringement risks
- Social uncertainties such as pandemic outbreaks
Innovations
2023: New Advanced Culture Facilities
- Overview
- New large-scale culture facilities installed to strengthen production capacity and quality control.
- Impact
- Improved production efficiency and contract project acquisition capabilities
2022: Introduction of Automation in Organic Synthesis Processes
- Overview
- Introduced automation systems for precision organic synthesis to improve production efficiency.
- Impact
- Contributes to reduced work time and stabilized quality
2021: Launch of Biotechnology Development Program
- Overview
- Strengthened research on cell culture technology and initiated commercialization studies.
- Impact
- Established foundation for new bio product development
2024: Adoption of Environmentally Considerate Manufacturing Technologies
- Overview
- Introduced manufacturing methods aimed at energy savings and waste reduction.
- Impact
- Significant reduction in environmental impact
2020: Advanced Quality Management System
- Overview
- Introduced latest analytical equipment to strengthen quality assurance system.
- Impact
- Contributes to improved product reliability
Sustainability
- Establishment of low-environmental-impact manufacturing processes
- Promotion of waste reduction and recycling
- Introduction of energy-saving equipment
- Promotion of participation in local environmental protection activities
- Employee environmental awareness training
- Development of sustainable chemical synthesis technologies
- Strengthened safety and health management system
- Promotion of green procurement policies
- Active utilization of ESG evaluations
- Promotion of social contribution activities